Publications by authors named "Sotirios Tsimikas"

100Publications

Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events.

J Am Heart Assoc 2020 Dec 23;9(23):e016318. Epub 2020 Nov 23.

Division of Cardiovascular Medicine Sulpizio Cardiovascular Center University of California, San Diego La Jolla CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.119.016318DOI Listing
December 2020

Genome-Wide Association Study Highlights as a Novel Locus for Lipoprotein(a) Levels.

Arterioscler Thromb Vasc Biol 2020 Oct 29:ATVBAHA120314965. Epub 2020 Oct 29.

Division of Experimental Medicine, McGill University, Montreal, Quebec. (M.H., H.Y.C., G.T., J.C.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.120.314965DOI Listing
October 2020

The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia.

Curr Opin Lipidol 2020 Dec;31(6):305-312

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, University of California San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000713DOI Listing
December 2020

A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.

J Bone Miner Res 2020 Sep 29. Epub 2020 Sep 29.

Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases and Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbmr.4173DOI Listing
September 2020

Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.

Curr Atheroscler Rep 2020 07 25;22(9):48. Epub 2020 Jul 25.

Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11883-020-00867-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381416PMC
July 2020

Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a).

J Lipid Res 2020 Sep 8;61(9):1263-1270. Epub 2020 Jul 8.

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, University of California San Diego, La Jolla, CA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.RA120000830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469883PMC
September 2020

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Reply.

N Engl J Med 2020 05;382(21):e65

Ionis Pharmaceuticals, Carlsbad, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc2004861DOI Listing
May 2020

Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytes.

Int J Cardiol 2020 09 7;315:81-85. Epub 2020 May 7.

Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands; Department of Internal Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, the Netherlands; Department of Hematology, Amsterdam University Medical Centers, VU University, Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2020.05.008DOI Listing
September 2020

From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases.

Eur Heart J 2020 Oct;41(40):3884-3899

Center for Molecular Cardiology, University of Zürich, Wagistrasse 12, 8952 Schlieren, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehaa229DOI Listing
October 2020

The dedicated "Lp(a) clinic": A concept whose time has arrived?

Atherosclerosis 2020 05 13;300:1-9. Epub 2020 Mar 13.

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla, CA, USA; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2020.03.003DOI Listing
May 2020

Ancient Remedy for a Modern Disease: Will Celastrol Become a Treatment for Aortic Valve Stenosis?

JACC Basic Transl Sci 2020 Jan 27;5(1):50-52. Epub 2020 Jan 27.

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiovascular Diseases, University of California-San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacbts.2019.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000881PMC
January 2020

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.

N Engl J Med 2020 01 1;382(3):244-255. Epub 2020 Jan 1.

From the Divisions of Cardiovascular Medicine (S.T.) and Endocrinology and Metabolism (J.L.W.), University of California, San Diego, La Jolla, and Ionis Pharmaceuticals, Carlsbad (S.T., S.X., N.J.V.) - both in California; Akcea Therapeutics, Boston (E.K.-P., J.G., L.O.); Polyclinic for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany (I.G.-B.); Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.); Excel Medical Clinical Trials, Boca Raton, FL (S.J.B.); the Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Berlin, Berlin Institute of Health, Berlin (E.S.-T.), and the Division of Geriatrics, University Medicine Greifswald, Greifswald (E.S.-T.) - both in Germany; the Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University, Portland (M.D.S.); the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S.); the Division of Clinical Pharmacology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City (P.M.M.); and the Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev (B.G.N.), and the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen (B.G.N.) - all in Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1905239DOI Listing
January 2020

Statins and increases in Lp(a): an inconvenient truth that needs attention.

Eur Heart J 2020 01;41(1):192-193

Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz776DOI Listing
January 2020

The challenges of measuring Lp(a): A fight against Hydra?

Atherosclerosis 2019 10 31;289:181-183. Epub 2019 Aug 31.

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiovascular Diseases, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2019.08.019DOI Listing
October 2019

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.

N Engl J Med 2019 08;381(6):531-542

From the Department of Medicine, University of California San Diego, La Jolla (J.L.W., S.T.), and Ionis Pharmaceuticals, Carlsbad (V.J.A., Q.Y., S.G.H., R.S.G., S.T.) - both in California; the Department of Medicine, Université de Montréal and ECOGENE 21, Chicoutimi, QC (D.G.), and the Department of Medicine and Laboratory Medicine, Centre Hospitalier Universitaire de Québec-University Laval, Quebec, QC (J.B.) - both in Canada; the Department of Medicine, Beth Israel Deaconess Medical Center (S.D.F.), and the Department of Medicine, Massachusetts General Hospital (L.H.), Boston, and Akcea Therapeutics, Cambridge (A.D., K.R.W., L.O.) - all in Massachusetts; Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Rome (M.A.); Academic Medical Center, Department of Vascular Medicine, Amsterdam (E.S.G.S.); the Department of Medicine, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); the Department of Internal Medicine, Hospital Universitario Miguel Servet, IIS Aragón, Universidad de Zaragoza, Zaragoza, Spain (F.C.); the Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa (D.J.B.); and the Department of Endocrinology and Cardiovascular Disease Prevention, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière Hospital, Institut de Création et d'Animation Numériques, Paris (E.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1715944DOI Listing
August 2019

Statin therapy increases lipoprotein(a) levels.

Eur Heart J 2020 Jun;41(24):2275-2284

Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0682, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz310DOI Listing
June 2020

In Search of Patients With Elevated Lp(a): Seek and Ye Shall Find.

J Am Coll Cardiol 2019 03;73(9):1040-1042

Division of Cardiovascular Medicine, University of California San Diego, La Jolla, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.12.036DOI Listing
March 2019

Lipid-Lowering Agents.

Circ Res 2019 02;124(3):386-404

Sulpizio Cardiovascular Center, Vascular Medicine Program, University of California San Diego, La Jolla (S.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.118.313171DOI Listing
February 2019

Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.

Circ Res 2019 02;124(3):405-415

From the Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California San Diego, La Jolla.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.118.313864DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361547PMC
February 2019

Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.

Angiology 2019 Apr 30;70(4):332-336. Epub 2019 Jan 30.

1 Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Vascular Medicine Program, University of California San Diego, San Diego, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319719826461DOI Listing
April 2019

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.

Lancet 2018 10 4;392(10155):1311-1320. Epub 2018 Oct 4.

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)31652-0DOI Listing
October 2018

Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.

J Clin Lipidol 2018 Nov - Dec;12(6):1493-1501.e11. Epub 2018 Aug 29.

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.08.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970616PMC
October 2019

RNA-targeted therapeutics for lipid disorders.

Curr Opin Lipidol 2018 12;29(6):459-466

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiovascular diseases, University of California San Diego School of Medicine, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000549DOI Listing
December 2018

Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform size.

J Clin Lipidol 2018 Sep - Oct;12(5):1313-1323. Epub 2018 Jul 20.

Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.07.003DOI Listing
October 2019

Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia.

JACC Cardiovasc Imaging 2019 08 19;12(8 Pt 1):1430-1440. Epub 2018 Jun 19.

Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcmg.2018.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458098PMC
August 2019

Oxidation-specific epitopes restrain bone formation.

Nat Commun 2018 06 6;9(1):2193. Epub 2018 Jun 6.

Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, 4301W. Markham, Little Rock, AR, 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-04047-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990540PMC
June 2018

In search of a physiological function of lipoprotein(a): causality of elevated Lp(a) levels and reduced incidence of type 2 diabetes.

J Lipid Res 2018 05 2;59(5):741-744. Epub 2018 Apr 2.

Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, University of California San Diego, La Jolla, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.C085639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928428PMC
May 2018

Relationship between "LDL-C", estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide.

J Clin Lipidol 2018 May - Jun;12(3):702-710. Epub 2018 Mar 1.

Ionis Pharmaceuticals, Carlsbad, CA, USA; Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.02.014DOI Listing
September 2019

Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease.

J Cardiovasc Transl Res 2018 06 17;11(3):221-229. Epub 2018 Jan 17.

Cardiovascular Research Center, University of Virginia, 415 Lane Road, Bldg MR-5, Rm-G231, Charlottesville, VA, 22908, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12265-018-9790-4
Publisher Site
http://dx.doi.org/10.1007/s12265-018-9790-4DOI Listing
June 2018

Plasma Proteomics for Epidemiology: Increasing Throughput With Standard-Flow Rates.

Circ Cardiovasc Genet 2017 Dec;10(6)

From the King's British Heart Foundation Centre, King's College London, United Kingdom (X.Y., F.B., E.H., H.H., M.M.); Agilent Technologies Ltd, Cheadle, United Kingdom (R.T.B., A.S.); Biognosys AG, Schlieren, Switzerland (T.G., S.M., L.R.); Department of Neurology, Medical University of Innsbruck, Austria (R.P., J.W., S.K.); School of Medicine, University of California San Diego (S.T., J.L.W.); and Department of Laboratory Medicine, Bruneck Hospital, Italy (P.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCGENETICS.117.001808DOI Listing
December 2017

Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a) and IONIS-APO(a)-L antisense oligonucleotide clinical trials.

J Clin Lipidol 2018 Jan - Feb;12(1):122-129.e2. Epub 2017 Nov 2.

Department of Medicine, Ionis Pharmaceuticals, Carlsbad, CA, USA; Department of Medicine, University of California San Diego, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19332874173049
Publisher Site
http://dx.doi.org/10.1016/j.jacl.2017.10.024DOI Listing
July 2019

Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.

J Clin Endocrinol Metab 2017 09;102(9):3340-3348

Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon 97239.

View Article

Download full-text PDF

Source
http://academic.oup.com/jcem/article/102/9/3340/3869385/Thre
Publisher Site
http://dx.doi.org/10.1210/jc.2016-4043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587068PMC
September 2017

Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.

Arterioscler Thromb Vasc Biol 2017 08 1;37(8):1570-1578. Epub 2017 Jun 1.

From the Department of Clinical Biochemistry (P.R.K., B.G.N.) and the Copenhagen General Population Study (P.R.K., B.G.N.), Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark; Department of Medicine, University of California San Diego, La Jolla (M.-Y.H., J.L.W., S.T.); Department of Internal Medicine, School of Medicine, College of Medicine (M.-Y.H.) and Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital (M.-Y.H.), Taipei Medical University, Taiwan; Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan (M.-Y.H.); and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (B.G.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.116.308761DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551411PMC
August 2017

Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.

N Engl J Med 2017 07 24;377(3):222-232. Epub 2017 May 24.

From Ionis Pharmaceuticals, Carlsbad (M.J.G., R.G.L., T.A.B., L.-J.T., W.F., R.P., R.Y., E.P., B.W.M., B.F.B., N.C.P., S.G.H., R.S.G., R.M.C., S.T.), and the University of California, San Diego, La Jolla (J.L.W., S.T.) - both in California; and Akcea Therapeutics, Cambridge, MA (E.H., A.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701329DOI Listing
July 2017

Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.

Arterioscler Thromb Vasc Biol 2017 06 4;37(6):1213-1221. Epub 2017 May 4.

From the Division of Cardiology, Department of Medicine, The University of Texas Health Science Center San Antonio (A.P.); Veterans Affairs Medical Center, San Diego, CA (P.C.); Division of Cardiology, University of Texas Southwestern Medical Center at Dallas (C.A., A.K., J.A.d.L.); Division of Endocrinology and Metabolism (J.L.W.) and Department of Medicine (S.T.), University of California San Diego, La Jolla; and Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, La Jolla, CA (S.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.117.309101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500201PMC
June 2017

Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.

Arterioscler Thromb Vasc Biol 2017 06 4;37(6):1206-1212. Epub 2017 May 4.

From the Department of Vascular Medicine (J.C.v.C., S.J.B.M., J.J.P.K., E.S.G.S., G.K.H.), Department of Clinical Epidemiology and Biostatistics (A.H.Z.), and Department of Cardiology (S.M.B.), Academic Medical Center, Amsterdam, The Netherlands; Vascular Medicine Program, Division of Cardiology (X.Y., S.T.) and Division of Endocrinology and Metabolism (J.L.W.), Department of Medicine, University of California San Diego, La Jolla; Medical Research Council Epidemiology Unit, Cambridge, United Kingdom (N.J.W.); and Department of Public Health and Primary Care, University of Cambridge, United Kingdom (K.-T.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.117.309007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484077PMC
June 2017

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.

Lancet Diabetes Endocrinol 2017 07 10;5(7):524-533. Epub 2017 Apr 10.

Medical Research Council (MRC)/British Heart Foundation (BHF) Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, UK; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK; National Institute for Health Research Blood and Transplant Research Unit, University of Cambridge, Cambridge, UK; Cambridge British Heart Foundation Centre of Excellence, University of Cambridge, Cambridge, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30088-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483508PMC
July 2017

Novel Lipoprotein(a) Catabolism Pathway via Apolipoprotein(a) Recycling: Adding the Plasminogen Receptor PlgR to the List.

Circ Res 2017 03;120(7):1050-1052

From the Department of Medicine, Division of Cardiovascular Medicine (C.Y., S.T.) and Division of Endocrinology and Metabolism (P.L.S.M.G.), University of California San Diego, La Jolla.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.117.310700DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470738PMC
March 2017

A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.

J Am Coll Cardiol 2017 Feb;69(6):692-711

Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California San Diego, La Jolla, California. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07351097163725
Publisher Site
http://dx.doi.org/10.1016/j.jacc.2016.11.042DOI Listing
February 2017

Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.

J Am Coll Cardiol 2017 Jan;69(2):147-158

Division of Cardiovascular Diseases, University of California, San Diego, La Jolla, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.10.057DOI Listing
January 2017

The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting.

Angiology 2017 Oct 10;68(9):795-798. Epub 2017 Jan 10.

1 Vascular Medicine Program, Sulpizio Cardiovascular Center, University of California, San Diego, San Diego, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319716688415DOI Listing
October 2017

Lipoprotein(a) Mass Levels Increase Significantly According to Genotype: An Analysis of 431 239 Patients.

Arterioscler Thromb Vasc Biol 2017 Mar 5;37(3):580-588. Epub 2017 Jan 5.

From the Division of Clinical Pharmacology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City (P.M.M.); Salveo Diagnostics, Inc, Richmond, VA (S.A.V., J.P.M.); Department of Cellular and Molecular Medicine, Glycobiology Research and Training Center (P.L.S.M.G.), Department of Medicine, Division of Endocrinology and Metabolism (P.L.S.M.G.), and Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center (S.T.), University of California San Diego, La Jolla.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.116.308704DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323356PMC
March 2017

Lipoprotein(a)-cholesterol levels estimated by vertical auto profile correlate poorly with Lp(a) mass in hyperlipidemic subjects: Implications for clinical practice interpretation of Lp(a)-mediated risk.

J Clin Lipidol 2016 Nov - Dec;10(6):1389-1396. Epub 2016 Sep 28.

Division of Cardiovascular Diseases, Department of Medicine, Sulpizio Cardiovascular Center, University of California, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2016.09.012DOI Listing
October 2017

LPA Gene, Ethnicity, and Cardiovascular Events.

Circulation 2017 Jan 9;135(3):251-263. Epub 2016 Nov 9.

From Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California San Diego, La Jolla (S.-R.L., Y.-S.C., S.T.); Division of Cardiology, Chonbuk National University Hospital and Chonbuk School of Medicine, Jeonju, Korea (S.-R.L.); Division of Cardiology, Department of Medicine, The University of Texas Health Science Center San Antonio (A.P.); Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul (Y.-S.C.); Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center at Dallas (C.X.); Veterans Affairs Medical Center, San Diego, CA (P.C.); and Division of Endocrinology and Metabolism, University of California San Diego, La Jolla (J.L.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024611DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241172PMC
January 2017

Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United States.

Arterioscler Thromb Vasc Biol 2016 11 22;36(11):2239-2245. Epub 2016 Sep 22.

From the Salveo Diagnostics, LLC, Richmond, VA (S.V., J.P.M.); and Department of Medicine, Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California San Diego, La Jolla (S.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.116.308011DOI Listing
November 2016

Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia.

J Clin Lipidol 2016 Jul-Aug;10(4):1011-1021. Epub 2016 May 9.

London School of Hygiene & Tropical Medicine, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2016.04.013DOI Listing
October 2017

The re-emergence of lipoprotein(a) in a broader clinical arena.

Prog Cardiovasc Dis 2016 Sep - Oct;59(2):135-144. Epub 2016 Aug 3.

Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California San Diego, La Jolla, CA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00330620163006
Publisher Site
http://dx.doi.org/10.1016/j.pcad.2016.07.005DOI Listing
May 2017

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.

Circulation 2016 Aug 5;134(8):611-24. Epub 2016 Aug 5.

From Department of Vascular Medicine (F.M.V.d.V., M.N., E.S.G.S.), Department of Molecular Cell Biology, Sanquin Research (J.K., J.D.v.B.), Experimental Vascular Biology, (J.v.d.B.), Department of Radiology (A.J.N.), and Department of Nuclear Medicine (H.J.V.), Academic Medical Center, Amsterdam, the Netherlands; Departments of Internal Medicine (S.B., L.A.B.J., M.G.N., N.P.R.) and Pharmacology-Toxicology (N.P.R.), Radboud UMC, Nijmegen, the Netherlands; Sulpizio Cardiovascular Center, Division of Cardiovascular Medicine (C.Y., S.T.) and Division of Endocrinology and Metabolism, Department of Medicine (J.L.W.), University California, San Diego, La Jolla; St. Boniface Hospital Research Centre, University of Manitoba, Winnipeg, Canada (A.R.); Department of Chemistry, Biochemistry and Pharmacology, University of Windsor, Windsor, Canada (C.S.); and Robarts Research Institute, Schulich School of Medicine, Western University, London, Canada (M.L.K.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.116.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.020838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995139PMC
August 2016

Elevated Lp(a) and Abdominal Aortic Aneurysm.

Angiology 2017 02 11;68(2):96-98. Epub 2016 Jul 11.

1 Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319716650960DOI Listing
February 2017

Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).

J Clin Lipidol 2016 May-Jun;10(3):594-603. Epub 2016 Mar 8.

Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2016.01.005DOI Listing
October 2017

Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.

Curr Opin Cardiol 2016 07;31(4):440-50

Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCO.0000000000000300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956483PMC
July 2016

PCSK9 Association With Lipoprotein(a).

Circ Res 2016 06 27;119(1):29-35. Epub 2016 Apr 27.

From the Department of Medicine, Center for Preventive Cardiology, Knight Cardiovascular Institute, Portland, OR (H.T., D.C., D.P., M.D.S., I.G., P.B.D., S.F.); School of Public Health, Oregon Health and Science University, Portland (J.M.); Sulpizio Cardiovascular Center, Vascular Medicine Program, University of California at San Diego, La Jolla (C.Y., S.T.); Inra UMR1280, Université de Nantes, CHU Hôtel-Dieu, Nantes, France (M.C., G.L.); Inserm UMR 1188, Sainte-Clotilde, France (G.L.); Université de la Réunion, Faculté de Médecine, Saint-Denis, France (G.L.); and CHU de la Réunion, Saint-Denis, France (G.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.116.308811DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920709PMC
June 2016

The role of lipoprotein(a) in progression of renal disease: Causality or reverse causality?

J Diabetes Complications 2016 07 7;30(5):755-7. Epub 2016 Apr 7.

Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California, La Jolla, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2016.04.001DOI Listing
July 2016

JCL Roundtable: Should we treat elevations in Lp(a)?

J Clin Lipidol 2016 Mar-Apr;10(2):215-24. Epub 2016 Mar 5.

Division of Cardiovascular Diseases, Department of Medicine, UCSD Cardiology La Jolla, Perlman Ambulatory Center, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2016.02.012DOI Listing
December 2016

Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.

Arterioscler Thromb Vasc Biol 2016 Apr 11;36(4):682-91. Epub 2016 Feb 11.

From the Cardiovascular Research Center (D.B.H., P.S., J.L.K., S.N.O., C.M.S., J.C.G., H.M.P., C.A.M.), Department of Biochemistry, Molecular Biology, and Genetics (D.B.H.), Division of Cardiovascular Medicine, Department of Medicine (P.S., A.M.T., C.A.M.), Department of Pathology (J.L.K., H.M.P.), Division of Endocrinology and Metabolism, Department of Medicine (J.L.K.), Department of Surgery (P.H., B.S.), Beirne B. Carter Center for Immunology Research (C.A.M.), Department of Molecular Physiology and Biological Physics (C.A.M.), University of Virginia, Charlottesville; and Department of Medicine, University of California San Diego, La Jolla (T.A.P., A.G., S.T., J.L.W.).

View Article

Download full-text PDF

Source
http://atvb.ahajournals.org/content/early/2016/02/11/ATVBAHA
Web Search
http://atvb.ahajournals.org/lookup/doi/10.1161/ATVBAHA.116.3
Publisher Site
http://dx.doi.org/10.1161/ATVBAHA.116.307166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808436PMC
April 2016

Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results.

J Lipid Res 2016 Apr 4;57(4):706-13. Epub 2016 Feb 4.

Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California San Diego, La Jolla, CA Ionis Pharmaceuticals, Carlsbad, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M066399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808774PMC
April 2016